Peer Review reports
From: Registration of phase 3 crossover trials on ClinicalTrials.gov
| Original Submission | ||
|---|---|---|
| 21 Feb 2020 | Submitted | Original manuscript |
| 14 Apr 2020 | Author responded | Author comments - Lijuan Zeng |
| Resubmission - Version 2 | ||
| 14 Apr 2020 | Submitted | Manuscript version 2 |
| 21 Apr 2020 | Reviewed | Reviewer Report - Karla Hemming |
| 5 May 2020 | Reviewed | Reviewer Report - Michael J. Grayling |
| 28 May 2020 | Author responded | Author comments - Lijuan Zeng |
| Resubmission - Version 3 | ||
| 28 May 2020 | Submitted | Manuscript version 3 |
| 1 Jun 2020 | Reviewed | Reviewer Report - Karla Hemming |
| 1 Jun 2020 | Reviewed | Reviewer Report - Michael J. Grayling |
| 17 Jun 2020 | Author responded | Author comments - Lijuan Zeng |
| Resubmission - Version 4 | ||
| 17 Jun 2020 | Submitted | Manuscript version 4 |
| Publishing | ||
| 22 Jun 2020 | Editorially accepted | |
| 6 Jul 2020 | Article published | 10.1186/s13063-020-04545-2 |
You can find further information about peer review here.